KMT2D and triple-negative breast carcinoma: Based on 101 triple-negative breast cancer mutation samples, eight genes with higher mutation rates (TP53, TTN, MUC4, KMT2D, PTEN, FAT3, MUC16, and SYNE1) were screened.